Kateryna Nesteruk
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Kateryna Nesteruk has a total of 17 co-authors. Here are the top co-authors by number of shared publications:
Anouk van de Winkel
Department of Gastroenterology and Hepatology, Erasmus MC - University Medical Center Rotterdam, Rotterdam, The Netherlands
1 shared publicationAuke P. Verhaar
Department of Gastroenterology and Hepatology, Erasmus MC - University Medical Center Rotterdam, Rotterdam, The Netherlands
1 shared publicationBingting Yu
Department of Gastroenterology and Hepatology, Erasmus MC - University Medical Center Rotterdam, Rotterdam, The Netherlands
1 shared publication- Ernst J. Kuipers
Department of Gastroenterology and Hepatology, Erasmus MC University Medical Center, Rotterdam, The Netherlands
1 shared publication Gwenny M. Fuhler
Department of Gastroenterology and Hepatology, Erasmus MC - University Medical Center Rotterdam, Rotterdam, The Netherlands
1 shared publicationH. Scott Stadler
Department of Skeletal Biology, Shriners Hospital for Children, Portland, USA
1 shared publication
Latest Publications
- Open Access
- 7 June 2021
- Published by Springer Nature in Nature Communications
- Vol. 12 (1) , 1-17
HOXA13 in etiology and oncogenic potential of Barrett’s esophagus
Barrett’s esophagus in gastrointestinal reflux patients constitutes a columnar epithelium with distal characteristics, prone to progress to esophageal adenocarcinoma.HOXgenes are known mediators of position-dependent morphology. Here we showHOXcollinearity in the adult gut while Barrett’s esophagus shows highHOXA13expression in stem cells and their progeny.HOXA13overexpression appears sufficient to explain both the phenotype (through downregulation of the epidermal differentiation complex) and the oncogenic potential of Barrett’s esophagus. Intriguingly, employing a mouse model that contains a reporter coupled to theHOXA13promotor we identify single HOXA13-positive cells distally from the physiological esophagus, which is mirrored in human physiology, but increased in Barrett’s esophagus. Additionally, we observe thatHOXA13expression confers a competitive advantage to cells. We thus propose that Barrett’s esophagus and associated esophageal adenocarcinoma is the consequence of expansion of this gastro-esophagealHOXA13-expressing compartment following epithelial injury.
- 7 June 2021
- Published by Springer Nature in Nature Communications
- Vol. 12 (1) , 1-17
Open AccessHOXA13 in etiology and oncogenic potential of Barrett’s esophagus
Barrett’s esophagus in gastrointestinal reflux patients constitutes a columnar epithelium with distal characteristics, prone to progress to esophageal adenocarcinoma.HOXgenes are known mediators of position-dependent morphology. Here we showHOXcollinearity in the adult gut while Barrett’s esophagus shows highHOXA13expression in stem cells and their progeny.HOXA13overexpression appears sufficient to explain both the phenotype (through downregulation of the epidermal differentiation complex) and the oncogenic potential of Barrett’s esophagus. Intriguingly, employing a mouse model that contains a reporter coupled to theHOXA13promotor we identify single HOXA13-positive cells distally from the physiological esophagus, which is mirrored in human physiology, but increased in Barrett’s esophagus. Additionally, we observe thatHOXA13expression confers a competitive advantage to cells. We thus propose that Barrett’s esophagus and associated esophageal adenocarcinoma is the consequence of expansion of this gastro-esophagealHOXA13-expressing compartment following epithelial injury.